Established in 2001 at the Gold Coast Campus of Griffith University, research at the Institute for Glycomics involves the study of the glycans and glycan-binding proteins in various biological systems, and the design of novel drugs and vaccines. This approach presents an exciting therapeutic platform for the control of a wide-range of medical conditions such as cancer, diabetes, infectious diseases, inflammation and immune disorders.

The Institute is the only one of its kind in Australia and only one of six in the world. We seek to collaborate with leading scientists around the world to build a critical mass around carbohydrate-based research. Global collaboration together with a mutil-disciplinary approach to research, are essential to achieving our vision to bring forward novel medicines and vaccines to the community.

For more information visit: http://www.griffith.edu.au/science/institute-glycomics